Shionogi & Co Ltd 4507.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 05/19/22 JST
6,748.00UNCH (UNCH)
52 week range
5,438.00 - 8,439.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6,748.00
  • 52 Week High8,439.00
  • 52 Week High Date11/25/21
  • 52 Week Low5,438.00
  • 52 Week Low Date06/02/21

Key Stats

  • Market Cap15,917.05M
  • Shares Out301.48M
  • 10 Day Average Volume1.68M
  • Dividend120.00
  • Dividend Yield1.78%
  • Beta-
  • YTD % Change-16.95

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6,748.00
  • 52 Week High8,439.00
  • 52 Week High Date11/25/21
  • 52 Week Low5,438.00
  • 52 Week Low Date06/02/21
  • Market Cap15,917.05M
  • Shares Out301.48M
  • 10 Day Average Volume1.68M
  • Dividend120.00
  • Dividend Yield1.78%
  • Beta-
  • YTD % Change-16.95

RATIOS/PROFITABILITY

  • EPS (TTM)451.10
  • P/E (TTM)14.96
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/30/2022
  • Div Amount60.00
  • Split Date-
  • Split Factor-

Latest On Shionogi & Co Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Shionogi & Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The prescription drug business is engaged in the development of eight new drugs including hypercholesterolemia treatment drugs Crestor, antihypertensive drugs Ilbetan Family (Irbetan, Aimix, Iltra) and antidepressant drugs Sinbalta. The Company is engaged in the provision of...
Isao Teshirogi
President, Chief Executive Officer, Representative Director
Takuko Sawada
Vice President, Chief Director of Health & Care Strategy, Director
Address
3-1-8, Dosho-machi, Chuo-ku
Osaka-shi, OSK
541-0045
Japan